Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.
PrivateLast Round
Series B
Aug 1, 2021
Company Overview
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is a biotechnology company that specializes in the research and development of personalized dendritic cell vaccines for the treatment of malignant solid tumors and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Comparables
Compare Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hengsai Biotechnology | 85% | |
| Diakonos Oncology | 82% | |
| Northwest Biotherapeutics Inc | 78% | |
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 1, 2021 | ||||
| Series A | Nov 16, 2020 | ||||
| VC Round | Jul 1, 2019 | ||||
| VC Round | Sep 1, 2018 |
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HMC Ventures | Series A |
| 北京首都科技发展集团有限公司 | VC Round |
| 华创资本 | VC Round |
| 久银控股 | Series B |
| Cowin Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2021
Raised Series B round with participation from 久银控股.
- Nov 16, 2020
Raised Series A led by HMC Ventures.
Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s valuation, stock price, and market status.